Tata Memorial Centre Clinical Trials
Sponsors / Tata Memorial Centre
Tata Memorial Centre appears as lead sponsor on 48 trial records in ClinicalTrials.gov. Of these, 26 are recruiting, 5 are active without new recruitment, and 9 have completed. The registry records 2 terminated or withdrawn trials for Tata Memorial Centre. The most common reasons cited for termination include slow or insufficient recruitment. Planned participant enrollment across these trials sums to 11,950. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
48
Total Trials
26
Recruiting
5
Other Active
9
Completed
2
Terminated / Withdrawn
11,950
Total Enrollment
Termination reasons: Recruitment50% · Other50%
Recent Terminations
- GVHD, Chronic"Issues with recruitment. Practice changes, including leflunomide use for CMV, have led to a lack of musculoskeletal GVHD cases. Only one patient enrolled in the trial will continue treatment as per standard care."
- Gastrointestinal Cancer"Two patients developed corneal laceration and hence study re-reviewed by IEC and decided to terminate the study prematurely"
Active Trials (5 total)
- NCT03997110
- NCT07395635
- NCT07338526
- Glioma PHASE2NCT07338539
- NCT07337850
- Rectal Neoplasms PHASE2NCT05856305
- NCT06831461
- Acute Leukemia PHASE2NCT06058572
- NCT05774483
- Advanced Cancer PHASE3NCT07062263
- NCT07021677
- NCT05857631
- DIPG PHASE2NCT04250064
- NCT04474964
- Gall Bladder Cancer PHASE2/PHASE3NCT06214572
- Neurocognitive Dysfunction PHASE3NCT06275035
- NCT06779487
- Breastcancer NANCT02992574
- NCT05450016
- NCT06252142